{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T05:32:04Z","timestamp":1782019924021,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2033,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.fertnstert.2016.08.010","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T22:38:15Z","timestamp":1472164695000},"page":"1530-1538.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells"],"prefix":"10.1016","volume":"106","author":[{"given":"Milijana","family":"Janjusevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Soriful","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ciavattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Toti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Petraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4400-3786","authenticated-orcid":false,"given":"Pasquapina","family":"Ciarmela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.08.010_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1126\/science.1112063","article-title":"Uterine fibroids: the elephant in the room","volume":"308","author":"Walker","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ajcp\/94.4.435","article-title":"The frequency of uterine leiomyomas","volume":"94","author":"Cramer","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0015-0282(16)45789-4","article-title":"Uterine leiomyomata: etiology, symptomatology, and management","volume":"36","author":"Buttram","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib5","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1210\/jc.2012-3237","article-title":"Uterine leiomyoma: available medical treatments and new possible therapeutic options","volume":"98","author":"Islam","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib7","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1095\/biolreprod.114.123794","article-title":"Tissue-specific stem cells in the myometrium and tumor-initiating cells in leiomyoma","volume":"91","author":"Ono","year":"2014","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.fertnstert.2014.04.051","article-title":"Current understanding of somatic stem cells in leiomyoma formation","volume":"102","author":"Mas","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmu048","article-title":"Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications","volume":"21","author":"Moravek","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib11","doi-asserted-by":"crossref","first-page":"17053","DOI":"10.1073\/pnas.1313650110","article-title":"Paracrine activation of WNT\/\u03b2-catenin pathway in uterine leiomyoma stem cells promotes tumor growth","volume":"110","author":"Ono","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/humupd\/dmv030","article-title":"Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth","volume":"21","author":"Commandeur","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2013.03.007","article-title":"Complex networks of multiple factors in the pathogenesis of uterine leiomyoma","volume":"100","author":"Islam","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0030-1251476","article-title":"Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder","volume":"28","author":"Chegini","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib15","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/humupd\/dmr031","article-title":"Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications","volume":"17","author":"Ciarmela","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1210\/jc.2010-0501","article-title":"Activin-A and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroid","volume":"96","author":"Ciarmela","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib17","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/en.2007-0692","article-title":"Activin-A in myometrium: characterization of the actions on myometrial cells","volume":"149","author":"Ciarmela","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib18","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1210\/en.2008-0880","article-title":"Presence, actions, and regulation of myostatin in rat uterus and myometrial cells","volume":"150","author":"Ciarmela","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bpobgyn.2015.08.018","article-title":"Growth factors and pathogenesis","volume":"34","author":"Islam","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib20","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1073\/pnas.1215759110","article-title":"Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway","volume":"110","author":"Varghese","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib21","doi-asserted-by":"crossref","first-page":"E775","DOI":"10.1210\/jc.2013-2623","article-title":"Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function","volume":"99","author":"Islam","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1095\/biolreprod.108.075887","article-title":"Reactive oxygen species mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells","volume":"82","author":"Mesquita","year":"2010","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0030-1251475","article-title":"Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women","volume":"28","author":"Malik","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1006914301565","article-title":"Extracellular matrix components in uterine leiomyoma and their alteration during the tumour growth","volume":"189","author":"Wolanska","year":"1998","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(00)00418-0","article-title":"Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation","volume":"73","author":"Arici","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib26","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1933719109343310","article-title":"Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas","volume":"16","author":"Norian","year":"2009","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib27","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/jcp.22907","article-title":"Possible role of RKIP in cytotrophoblast migration: immunohistochemical and in\u00a0vitro studies","volume":"227","author":"Ciarmela","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib28","doi-asserted-by":"crossref","first-page":"23407","DOI":"10.1074\/jbc.M112.363812","article-title":"Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2","volume":"287","author":"Deiss","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/43686","article-title":"Suppression of Raf\u20131 kinase activity and MAP kinase signalling by RKIP","volume":"401","author":"Yeung","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib30","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1158\/0008-5472.CAN-10-3102","article-title":"Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3\u03b2","volume":"71","author":"Al-Mulla","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3410\/B2-82","article-title":"Does GSK-3 provide a shortcut for PI3K activation of Wnt signalling?","volume":"2","author":"Voskas","year":"2010","journal-title":"F1000 Biol Rep"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib32","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/jcp.24335","article-title":"RKIP: much more than Raf kinase inhibitory protein","volume":"228","author":"Al-Mulla","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jcb.20169","article-title":"The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein","volume":"94","author":"Keller","year":"2005","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.cad.0000136877.89057.b9","article-title":"Metastasis suppressor genes: a role for raf kinase inhibitor protein (RKIP)","volume":"15","author":"Keller","year":"2004","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib35","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1053\/j.gastro.2006.07.012","article-title":"Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells","volume":"131","author":"Lee","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/1439-7633(20021104)3:11<1105::AID-CBIC1105>3.0.CO;2-S","article-title":"A non-antibacterial oxazolidinone derivative that inhibits epithelial cell sheet migration","volume":"3","author":"McHenry","year":"2002","journal-title":"Chembiochem"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib37","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.chembiol.2005.07.007","article-title":"A chemical inhibitor reveals the role of Raf kinase inhibitor protein in cell migration","volume":"12","author":"Zhu","year":"2005","journal-title":"Chem Biol"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib38","first-page":"47","article-title":"Locostatin disrupts association of Raf kinase inhibitor protein with binding proteins by modifying a conserved histidine residue in the ligand-binding pocket","volume":"2","author":"Beshir","year":"2011","journal-title":"For Immunopathol Dis Therap"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib39","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.fertnstert.2006.08.111","article-title":"Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays","volume":"87","author":"Malik","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib40","first-page":"900","article-title":"Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle","volume":"79","author":"Stewart","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib41","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/jnci\/95.12.878","article-title":"Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis","volume":"95","author":"Fu","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1478-3231.2009.01981.x","article-title":"Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells","volume":"29","author":"Ma","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2174\/1568026033452348","article-title":"Small-molecule inhibitors of actin dynamics and cell motility","volume":"3","author":"Fenteany","year":"2003","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib44","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1172\/JCI64149","article-title":"GSK3\u03b2 regulates physiological migration of stem\/progenitor cells via cytoskeletal rearrangement","volume":"123","author":"Lapid","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2016.08.010_bib45","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1046\/j.0953-816x.2001.01572.x","article-title":"Activation of glycogen synthase kinase 3 beta (GSK-3\u03b2) by platelet activating factor mediates migration and cell death in cerebellar granule neurons","volume":"13","author":"Tong","year":"2001","journal-title":"Eur J Neurosci"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216626791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216626791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T11:51:18Z","timestamp":1768909878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216626791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0015028216626791"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.08.010","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a92016 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}